46. Consider the information concerning the costs and QALYS for various treatments for cancer that is presented in the table below. Which of the treatments is/are dominated? Cost per Cancer Treatment QALYS Gained Treatment H. 200 8. 400 10 500 12 600 700 14 O a.G. O b. H. OCK OdL Oe None of the above

46. Consider the information concerning the costs and QALYS for various treatments for cancer that is presented in the table below. Which of the treatments is/are dominated? Cost per Cancer Treatment QALYS Gained Treatment H. 200 8. 400 10 500 12 600 700 14 O a.G. O b. H. OCK OdL Oe None of the above

Principles of Economics 2e

2nd Edition

ISBN:9781947172364

Author:Steven A. Greenlaw; David Shapiro

Publisher:Steven A. Greenlaw; David Shapiro

Chapter16: Information, Risk, And Insurance

Section: Chapter Questions

Problem 18RQ: What are some of the metrics economists use to measure health outcomes?

See similar textbooks

Similar questions

For Pancreas Transplant, DRG code is 010. For DRG 010, Medicare pays fixed amountof $21,313.50. Outlier threshold for Medicare is $25,800. (a) John admitted hospital A for pancreas transplant. The charges for John’s treatment was 128,000. Cost to charge ratio for Hospital A was 0.10. How much payment hospital A would get from Medicare?
For 11-18: GIVEN TREATMEN T CHOICES Treatment COST LIFE Treatment D $15,000 31 Treatment $17,000 29 W no treatment EXPECTANCY Treatment B $7,000 18 Treatment C $11,000 26 Treatment Y $9,000 19 Treatment X $13,000 23 Treatment A $3,000 10 Treatment Z $5,000 16 $0 2 11. Which of the following is true? A) X OD C B) W is OD by C C) COD W D) W is OD by D B) X only C) X and W D) W only years years years years years years years years years E) all the choices are true 12. Identify all the obviously dominated treatments A) A and Z 13. Name all the obviously DOMINATING treatments. (only the treatments that obviously dominate other treatment(s) A) Y and B B) X and W C) C only D) C and D E) A,Z,B,Y,Z,D: all these treatments that are not obviously dominated, obviously dominate some treatment
Why is it important for decision-makers in a county council to take cost-effectiveness into account when making decisions tointroduce a new treatment in the county council?
For Pancreas Transplant, DRG code is 010. For DRG 010, Medicare pays fixed amount of $21,313.50. Outlier threshold for Medicare is $25,800. (a) John admitted hospital A for pancreas transplant. The charges for John’s treatment was 128,000. Cost to charge ratio for Hospital A was 0.10. How much payment hospital A would get from Medicare? (b) Bryan admitted hospital B for pancreas transplant. The charges for Bryan’s treatment was same as John, $128,000, but cost to charge ratio for Hospital B was 0.25. How much payment hospital B would get from Medicare?
9. Consider the following hypothetical three-stage screening test for a cancer with the following rates of detection and costs: Stage 2 3 Number of Cases Detected 100 110 125 135 Total $150,000 $180,000 $250.000 $310.000 A. Calculate the average cost per cancer detected in the three stages. B. Calculate the marginal cost per cancer detected in the three stages. C. Suppose that the marginal benefit per treated case is $4,600 per person. What would be the optimal screening, given the costs?
Which of he following provisions of an individual Accident and Heallh policy allows for nonpayment of premiums in lhe event of the insured's total disability? A.Grace Period B.Elimination Period C.Waiver of Premium D.Return of Premium
What is the problem of moral hazard?
What are some of the metrics economists use to measure health outcomes?
this is data.. do this. dont need refernece of Q1 Data: 8 27 24 25 11 18 22 28 21 11
4 discuss the importance of comparing the best alternatives in economics for health care managers
EconomyAs drug industryâ€™s influence over research grows, sodoes the potential for biasBy Peter Whoriskey November 24, 2012For drugmaker GlaxoSmithKline, the 17Âpage article in the New England Journal of Medicine represented a coup.The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the companyâ€™snew drug, performed best.â€œWe now have clear evidence from a large international study that the initial use of [Avandia] is more effective thanstandard therapies,â€ a senior vice president of GlaxoSmithKline, Lawson Macartney, said in a news release.What only careful readers of the article would have gleaned is the extent of the financial connections between thedrugmaker and the research. The trial had been funded by GlaxoSmithKline, and each of the 11 authors had receivedmoney from the company. Four were employees and held company stock. The other seven were academic…
DO NOT COPY PREVIOUS ANS. please provide detailed, step by step explination. If you dont know, dont answer.